CDC14A
Basic information
Region (hg38): 1:100325629-100520277
Previous symbols: [ "DFNB32" ]
Links
Phenotypes
GenCC
Source:
- hearing loss, autosomal recessive (Supportive), mode of inheritance: AR
- hearing impairment and infertile male syndrome (Strong), mode of inheritance: AR
- nonsyndromic genetic hearing loss (Limited), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 32 (Strong), mode of inheritance: AR
- autosomal recessive nonsyndromic hearing loss 32 (Limited), mode of inheritance: AR
- autosomal recessive nonsyndromic deafness 105 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Deafness, autosomal recessive 32, with or without immotile sperm | AR | Audiologic/Otolaryngologic | Early recognition and treatment of hearing impairment may improve outcomes, including speech and language development | Audiologic/Otolaryngologic; Genitourinary | 27259055; 29293958 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (6 variants)
- Autosomal recessive nonsyndromic hearing loss 32 (2 variants)
- Sensorineural hearing loss disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CDC14A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 25 | 32 | ||||
missense | 58 | 75 | ||||
nonsense | 9 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 3 | 2 | 6 | ||
non coding | 34 | 38 | 72 | |||
Total | 8 | 8 | 66 | 68 | 47 |
Highest pathogenic variant AF is 0.0000131
Variants in CDC14A
This is a list of pathogenic ClinVar variants found in the CDC14A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-100351784-A-G | Likely benign (Jul 01, 2024) | |||
1-100352197-G-A | Likely benign (Mar 28, 2019) | |||
1-100352198-C-G | Likely benign (Mar 28, 2019) | |||
1-100352485-A-G | Likely benign (Mar 03, 2019) | |||
1-100352622-G-C | Benign (Nov 10, 2018) | |||
1-100352730-A-T | Benign (Nov 10, 2018) | |||
1-100352908-T-C | Autosomal recessive nonsyndromic hearing loss 32 | Benign (Jul 14, 2021) | ||
1-100352908-T-T | not specified | Likely benign (Nov 10, 2017) | ||
1-100352940-CG-C | not specified | Likely benign (Dec 04, 2017) | ||
1-100352982-G-C | not specified | Conflicting classifications of pathogenicity (Mar 11, 2019) | ||
1-100352985-G-A | not specified | Conflicting classifications of pathogenicity (Apr 01, 2024) | ||
1-100352989-G-A | Inborn genetic diseases | Uncertain significance (Jul 31, 2024) | ||
1-100352997-A-G | Uncertain significance (Jun 06, 2024) | |||
1-100353013-A-T | CDC14A-related disorder | Likely benign (Jan 10, 2020) | ||
1-100353138-A-G | Likely benign (Feb 14, 2019) | |||
1-100353172-T-G | Benign (Nov 10, 2018) | |||
1-100353717-T-C | Benign (Jun 14, 2018) | |||
1-100353751-T-G | Likely benign (Jun 23, 2023) | |||
1-100353761-G-T | Autosomal recessive nonsyndromic hearing loss 32 | Likely pathogenic (Aug 01, 2020) | ||
1-100353772-T-C | Likely benign (Jul 06, 2022) | |||
1-100353810-A-G | Uncertain significance (Aug 22, 2022) | |||
1-100354133-C-G | Likely benign (Jan 02, 2019) | |||
1-100377253-T-C | Likely benign (Jan 25, 2019) | |||
1-100377317-G-T | Benign (Dec 23, 2018) | |||
1-100377597-C-T | not specified • CDC14A-related disorder | Likely benign (Feb 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CDC14A | protein_coding | protein_coding | ENST00000361544 | 15 | 175250 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
9.64e-8 | 0.996 | 125696 | 0 | 52 | 125748 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.494 | 309 | 334 | 0.924 | 0.0000172 | 4066 |
Missense in Polyphen | 58 | 85.365 | 0.67944 | 1077 | ||
Synonymous | -1.26 | 147 | 129 | 1.14 | 0.00000693 | 1194 |
Loss of Function | 2.62 | 17 | 33.3 | 0.510 | 0.00000188 | 413 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000782 | 0.000720 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.0000578 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000168 | 0.000167 |
Middle Eastern | 0.0000578 | 0.0000544 |
South Asian | 0.000238 | 0.000229 |
Other | 0.000507 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Dual-specificity phosphatase. Required for centrosome separation and productive cytokinesis during cell division. Dephosphorylates SIRT2 around early anaphase. May dephosphorylate the APC subunit FZR1/CDH1, thereby promoting APC-FZR1 dependent degradation of mitotic cyclins and subsequent exit from mitosis. {ECO:0000269|PubMed:11901424, ECO:0000269|PubMed:12134069, ECO:0000269|PubMed:17488717, ECO:0000269|PubMed:9367992}.;
- Disease
- DISEASE: Deafness, autosomal recessive, 105 (DFNB105) [MIM:616958]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:27259055}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Cell cycle - Homo sapiens (human);Cell Cycle;Signal Transduction;MAPK6/MAPK4 signaling;MAPK family signaling cascades;Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase;APC/C-mediated degradation of cell cycle proteins;Regulation of mitotic cell cycle;Cell Cycle;Cell Cycle, Mitotic
(Consensus)
Recessive Scores
- pRec
- 0.126
Intolerance Scores
- loftool
- 0.708
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.93
Haploinsufficiency Scores
- pHI
- 0.855
- hipred
- Y
- hipred_score
- 0.666
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.443
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cdc14a
- Phenotype
Zebrafish Information Network
- Gene name
- cdc14aa
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- microtubule cytoskeleton organization;mitotic cell cycle;regulation of exit from mitosis;sensory perception of sound;cell population proliferation;positive regulation of cytokinesis;peptidyl-tyrosine dephosphorylation;cell division;mitotic cell cycle arrest
- Cellular component
- spindle pole;nucleoplasm;nucleolus;cytoplasm;centrosome;cytosol;nuclear body;stereocilium tip;kinocilium;mitotic spindle;kinociliary basal body
- Molecular function
- phosphoprotein phosphatase activity;protein serine/threonine phosphatase activity;protein tyrosine phosphatase activity;protein binding;protein tyrosine/serine/threonine phosphatase activity